- Home
- TRST vs ABUS Comparison
TRST vs ABUS Comparison
Compare TRST & ABUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRST
- ABUS
- Stock Information
- Founded
- TRST 1902
- ABUS N/A
- Country
- TRST United States
- ABUS United States
- Employees
- TRST N/A
- ABUS N/A
- Industry
- TRST Major Banks
- ABUS Biotechnology: Pharmaceutical Preparations
- Sector
- TRST Finance
- ABUS Health Care
- Exchange
- TRST Nasdaq
- ABUS Nasdaq
- Market Cap
- TRST 642.6M
- ABUS 697.3M
- IPO Year
- TRST N/A
- ABUS N/A
- Fundamental
- Price
- TRST $33.57
- ABUS $3.21
- Analyst Decision
- TRST
- ABUS Strong Buy
- Analyst Count
- TRST 0
- ABUS 4
- Target Price
- TRST N/A
- ABUS $5.50
- AVG Volume (30 Days)
- TRST 117.2K
- ABUS 903.4K
- Earning Date
- TRST 01-21-2025
- ABUS 11-06-2024
- Dividend Yield
- TRST 4.29%
- ABUS N/A
- EPS Growth
- TRST N/A
- ABUS N/A
- EPS
- TRST 2.48
- ABUS N/A
- Revenue
- TRST $168,593,000.00
- ABUS $6,742,000.00
- Revenue This Year
- TRST N/A
- ABUS N/A
- Revenue Next Year
- TRST $11.69
- ABUS N/A
- P/E Ratio
- TRST $13.54
- ABUS N/A
- Revenue Growth
- TRST N/A
- ABUS N/A
- 52 Week Low
- TRST $25.83
- ABUS $2.21
- 52 Week High
- TRST $38.89
- ABUS $4.72
- Technical
- Relative Strength Index (RSI)
- TRST 34.95
- ABUS 33.77
- Support Level
- TRST $36.16
- ABUS $3.13
- Resistance Level
- TRST $37.87
- ABUS $3.61
- Average True Range (ATR)
- TRST 1.31
- ABUS 0.17
- MACD
- TRST -0.48
- ABUS -0.03
- Stochastic Oscillator
- TRST 10.23
- ABUS 12.12
About TRST TrustCo Bank Corp NY
Trustco Bank Corp N Y is a savings and loan holding company. The core part of a business consists of accepting deposits and making loans and investments. It offers a range of both personal and business banking services. The company's product includes savings accounts; retirement accounts; money market account; mortgages; building loans; auto loans and others. The Company based on only one business segment, that of community banking. TrustCo lends in the geographic territory of its branch locations in New York, Florida, Massachusetts, New Jersey and Vermont.
About ABUS Arbutus Biopharma Corporation
Arbutus Biopharma Corp is a biopharmaceutical company. The company discovers, develops, and commercializes cures for patients suffering from Hepatitis B infection. The company is focused on developing a portfolio of drug candidates with multiple mechanisms of action and is also involved in licensing Lipid nanoparticle technology.